Connect with:
Friday / November 8. 2024

logo
mobile-logo
HomePosts Tagged "Financial results for Q2 FY25"
Agribusiness, Biofuel industry, Company News, Finance, India

Company’s Profit After Tax stood at Rs. 538.310 million in Q2FY25.

Praj Industries (Praj), announced its unaudited financial results for the quarter ended Sept 30, 2024.Company’s income from operations stood at Rs. 8,161.920 million in Q2FY25 (Q1 FY25: Rs. 6,991.414 million; Q2 FY24: Rs 8,823.685 million). Company reported Profit Before Tax (PBT) Rs 744.419 million for the period (Q1 FY25: Rs. 788.805 million; Q2 FY24: Rs 848.121 million). Company’s Profit After Tax is at Rs. 538.310 million in Q2FY25 (Q1 FY25: Rs. 841.807 million; Q2 FY24: 623.679 million). Order intake during the quarter Rs. 9,210 million (Q1 FY25: 8,880 million; Q2 FY24: Rs. 10,630 million)

In H1FY25 Company’s Income from operations stood at Rs. 15,153.334 million (H1 FY24: Rs. 16,190.912 million). Company’s PBT before exceptional items is at Rs. 1,533.224 million for the period (H1 FY24: Rs. 1,625.154 million). PBT after exceptional items Rs. 1,814.796 million. In H1FY25 company’s PAT stood at Rs. 1,380.117 million (H1 FY24: Rs. 1,210.405 million). Order intake Rs.18,090 million (H1 FY24: Rs. 21,640 million)

Commenting on the Company’s performance, Shishir Joshipura, CEO & MD, Praj Industries said, “The Bioenergy segment continues to develop positively as we witness our business growing in multiple dimensions, with healthy order and enquiry inflows from international, services and engineering verticals in the first half of the year. Several positive developments in the ecosystem and market augur well for continued growth journey as we move forward. Commissioning of our Demo plant for biopolymers opens a completely new dimension in form of renewable chemicals and materials segment. Our strong focus on R&D backed solutions will continue help us stay on our envisioned growth path”.

Key Developments:

 Inauguration of India’s first-of-its-kind Demo Facility for Biopolymers, showcasing indigenously developed integrated Polylactic Acid (PLA) technology at the hands of Union Minister, Dr Jitendra Singh, Ministry of Science & Technology, in the presence of Dr Rajesh Gokhale, Secretary, Dept. of Biotechnology (DBT) and Dr. Ashish Lele (NCL).

Company’s Profit After Tax stood at Rs.

Agribusiness, Agro chems – Chemicals, Company News, Finance, India

Company posted Revenue from Operations at Rs. 746.6 Crore in Q2 FY25.

Best Agrolife Limited, amongst India’s leading agrochemicals manufacturers, announced its unaudited financial results for the quarter and half year ended September 30th, 2024, in the Board meeting held on 18th October, 2024.

 Company’s Q2 FY25 Revenue from Operations declined by 8 per cent YoY to Rs. 746.6 crore in Q2 FY25 compared to Rs. 811.2 crore in Q2 FY24 due to lesser sprays on account of continuous rains and a strategic higher focus on branded sales. Branded sales contributed 65 per cent to the overall revenue as compared to 63 per cent in Q2FY24. Q2 FY25 EBITDA was at Rs. 147.1 crore compared to Rs. 144.1 crore in Q2 FY24. EBITDA margin stood at 19.7 per cent with an increase of 193 Bps on YoY basis, mainly on account of stability in raw material prices & higher sales of branded products. Company’s Q2 FY25 PAT stood at Rs. 94.7 crore compared to Rs. 94.9 crore in Q2 FY24. As on September 30, 2024, the Net Debt to equity has improved to 0.59 as compared to 0.90 as on 31st March 2024.

Commenting on the result and overall update on the Q2 FY25, Vimal Kumar, Managing Director, Best Agrolife Ltd. said, “We are pleased to announce that Best Agrolife Ltd. has delivered a strong performance in Q2 FY25, capitalising on favourable market conditions and executing our strategic shift toward branded sales. Our commitment to enhancing brand visibility and expanding our market presence has yielded positive results, contributing significantly to both top-line and bottom-line growth.”

During H1 FY25, we secured three key patents for our innovative formulations, reinforcing our leadership in the crop protection segment. Our branded products continued to perform exceptionally well across regions, driving overall revenue growth. As a result of these efforts, we saw a substantial improvement in profitability, with our margins expanding from 26 per cent to 34 per cent year-on-year.

Due to our effective working capital management, we have seen a significant improvement in cash flow from operating activities, rising from Rs 5 crores in H1FY24 to Rs 125 crores in H1FY25, reflecting our ongoing focus on optimizing financial performance.

A notable achievement has been the effective management of sales returns-a challenge we faced in the previous fiscal year. By optimizing our supply chain to better align with channel demand, we successfully reduced sales returns, which are expected to remain significantly lower than last year.

“Looking ahead, we are excited about our strong product pipeline for Q3 and Q4 FY25. In the upcoming quarter, we plan to launch our patented herbicide ‘Shot Down’ alongside a new insecticide. Additionally, two more cutting-edge insecticides are slated for release in Q4, further strengthening our product portfolio and market competitiveness. As we move forward, Best Agrolife remains committed to leveraging innovation, expanding brand presence, and maintaining financial discipline to drive sustainable growth in the coming quarters.”

Business Highlights

The Company was granted a patent for its novel ternary pesticide formulation that integrates Isoprothiolane, Pymetrozine, and Trifloxystrobin; as well as one for its fungicide formulation that combines Trifloxystrobin and Valifenalate.

Best Agrolife received a patent for innovative insecticide formulation ‘Nemagen’ that combines Chlorantraniliprole, Novaluron, and Emamectin Benzoate.

The Company received regulatory approval for Nemagen, an insecticide formulation called to target resistant pests causing major crop damage.

Company posted Revenue from Operations at Rs.